Abhishek Goyal, M.B.,B.S.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Seasons | 2 | 2019 | 1524 | 0.790 |
Why?
|
Hemochromatosis | 1 | 2020 | 176 | 0.640 |
Why?
|
Cardiomyopathy, Dilated | 1 | 2020 | 843 | 0.460 |
Why?
|
India | 8 | 2024 | 2334 | 0.430 |
Why?
|
Aorta | 1 | 2021 | 2046 | 0.420 |
Why?
|
Urban Population | 2 | 2017 | 2046 | 0.410 |
Why?
|
Coronary Vessels | 2 | 2021 | 3124 | 0.400 |
Why?
|
beta Carotene | 1 | 2013 | 523 | 0.390 |
Why?
|
Primary Prevention | 1 | 2018 | 1187 | 0.360 |
Why?
|
Selenium | 1 | 2013 | 418 | 0.350 |
Why?
|
Vitamin A | 1 | 2013 | 611 | 0.350 |
Why?
|
Ascorbic Acid | 1 | 2013 | 658 | 0.340 |
Why?
|
Rural Population | 2 | 2017 | 2325 | 0.340 |
Why?
|
Hypercholesterolemia | 1 | 2016 | 1145 | 0.320 |
Why?
|
Anticholesteremic Agents | 1 | 2016 | 972 | 0.320 |
Why?
|
Circadian Rhythm | 1 | 2019 | 2593 | 0.280 |
Why?
|
Coronary Angiography | 4 | 2024 | 4541 | 0.260 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3253 | 0.210 |
Why?
|
Cardiovascular Diseases | 4 | 2018 | 15661 | 0.200 |
Why?
|
Shock, Cardiogenic | 2 | 2018 | 711 | 0.190 |
Why?
|
Acute Coronary Syndrome | 2 | 2024 | 2194 | 0.180 |
Why?
|
Hypertension | 2 | 2019 | 8617 | 0.180 |
Why?
|
Hospitalization | 1 | 2020 | 10847 | 0.180 |
Why?
|
Mass Screening | 1 | 2016 | 5457 | 0.170 |
Why?
|
Risk Assessment | 3 | 2018 | 24333 | 0.170 |
Why?
|
GPI-Linked Proteins | 1 | 2020 | 472 | 0.160 |
Why?
|
Aortic Rupture | 1 | 2022 | 322 | 0.160 |
Why?
|
Nutrition Surveys | 2 | 2018 | 1738 | 0.150 |
Why?
|
Blood Gas Analysis | 1 | 2019 | 384 | 0.150 |
Why?
|
Coronary Vasospasm | 1 | 2018 | 81 | 0.150 |
Why?
|
Aneurysm | 1 | 2021 | 343 | 0.150 |
Why?
|
Catheters | 1 | 2021 | 427 | 0.150 |
Why?
|
Back Pain | 1 | 2022 | 548 | 0.150 |
Why?
|
Myocardial Stunning | 1 | 2017 | 67 | 0.140 |
Why?
|
Checklist | 1 | 2024 | 841 | 0.140 |
Why?
|
Diuretics | 1 | 2020 | 614 | 0.140 |
Why?
|
Blood Pressure Monitoring, Ambulatory | 1 | 2019 | 252 | 0.140 |
Why?
|
Thymoma | 1 | 2018 | 191 | 0.140 |
Why?
|
Phosphines | 1 | 2016 | 18 | 0.130 |
Why?
|
Habits | 1 | 2017 | 148 | 0.130 |
Why?
|
Aluminum Compounds | 1 | 2016 | 56 | 0.130 |
Why?
|
Heart Failure | 1 | 2020 | 11879 | 0.130 |
Why?
|
Stents | 2 | 2018 | 3200 | 0.130 |
Why?
|
Aspergillosis | 1 | 2017 | 242 | 0.120 |
Why?
|
Substance-Related Disorders | 2 | 2024 | 4423 | 0.120 |
Why?
|
Morbidity | 2 | 2017 | 1757 | 0.120 |
Why?
|
Coronary Thrombosis | 1 | 2018 | 440 | 0.120 |
Why?
|
Eligibility Determination | 1 | 2018 | 421 | 0.120 |
Why?
|
Aortic Aneurysm, Thoracic | 1 | 2021 | 709 | 0.120 |
Why?
|
Angina Pectoris | 1 | 2018 | 957 | 0.110 |
Why?
|
American Heart Association | 1 | 2018 | 1051 | 0.110 |
Why?
|
Adult | 13 | 2024 | 223851 | 0.110 |
Why?
|
Pharmaceutical Preparations | 1 | 2021 | 1088 | 0.110 |
Why?
|
Endocarditis | 1 | 2017 | 352 | 0.100 |
Why?
|
Male | 19 | 2024 | 365203 | 0.100 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2022 | 1252 | 0.100 |
Why?
|
Prosthesis-Related Infections | 1 | 2017 | 497 | 0.100 |
Why?
|
Dyslipidemias | 1 | 2019 | 873 | 0.090 |
Why?
|
Pacemaker, Artificial | 1 | 2017 | 828 | 0.090 |
Why?
|
Patient Discharge | 1 | 2024 | 3491 | 0.090 |
Why?
|
Humans | 25 | 2024 | 768970 | 0.090 |
Why?
|
Neoplasms, Second Primary | 1 | 2018 | 1060 | 0.090 |
Why?
|
Health Education | 1 | 2017 | 1059 | 0.090 |
Why?
|
Prospective Studies | 6 | 2024 | 54962 | 0.080 |
Why?
|
Middle Aged | 13 | 2024 | 223737 | 0.080 |
Why?
|
Acute Disease | 1 | 2020 | 7245 | 0.080 |
Why?
|
Follow-Up Studies | 5 | 2024 | 39394 | 0.080 |
Why?
|
Time Factors | 4 | 2019 | 40261 | 0.080 |
Why?
|
Female | 15 | 2024 | 397515 | 0.080 |
Why?
|
Acute Kidney Injury | 1 | 2021 | 1936 | 0.080 |
Why?
|
Risk Factors | 7 | 2024 | 74976 | 0.070 |
Why?
|
Body Mass Index | 2 | 2017 | 13055 | 0.070 |
Why?
|
Troponin | 2 | 2023 | 535 | 0.070 |
Why?
|
Electronic Health Records | 1 | 2024 | 4879 | 0.070 |
Why?
|
Length of Stay | 1 | 2020 | 6526 | 0.070 |
Why?
|
United States | 5 | 2019 | 73186 | 0.070 |
Why?
|
Diabetes Complications | 1 | 2012 | 1320 | 0.060 |
Why?
|
Incidence | 3 | 2024 | 21547 | 0.060 |
Why?
|
Health Behavior | 1 | 2017 | 2649 | 0.060 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2016 | 1483 | 0.060 |
Why?
|
Retrospective Studies | 7 | 2024 | 81903 | 0.060 |
Why?
|
Heart | 1 | 2017 | 4447 | 0.060 |
Why?
|
Neoplasms | 1 | 2013 | 22389 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10633 | 0.060 |
Why?
|
Obesity | 2 | 2019 | 13091 | 0.050 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6569 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2019 | 26395 | 0.050 |
Why?
|
Hospitals, Community | 1 | 2024 | 365 | 0.050 |
Why?
|
Smoking | 1 | 2019 | 9094 | 0.050 |
Why?
|
Blood Pressure | 1 | 2017 | 8544 | 0.050 |
Why?
|
Age Factors | 1 | 2018 | 18435 | 0.050 |
Why?
|
Young Adult | 3 | 2024 | 60131 | 0.050 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7460 | 0.050 |
Why?
|
Diabetes Mellitus | 1 | 2019 | 5892 | 0.040 |
Why?
|
Liver Transplantation | 1 | 2012 | 2403 | 0.040 |
Why?
|
Atherosclerosis | 1 | 2016 | 3431 | 0.040 |
Why?
|
Aortography | 1 | 2022 | 422 | 0.040 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2012 | 2336 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 30046 | 0.040 |
Why?
|
Tachycardia | 1 | 2022 | 599 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2021 | 282 | 0.040 |
Why?
|
Aged | 7 | 2024 | 171786 | 0.040 |
Why?
|
Vena Cava, Inferior | 1 | 2022 | 463 | 0.040 |
Why?
|
Arteriovenous Fistula | 1 | 2022 | 320 | 0.040 |
Why?
|
Diltiazem | 1 | 2018 | 132 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2019 | 11521 | 0.040 |
Why?
|
Electrocardiography | 2 | 2023 | 6413 | 0.040 |
Why?
|
Aspergillus | 1 | 2017 | 95 | 0.040 |
Why?
|
Creatine Kinase, MB Form | 1 | 2017 | 202 | 0.030 |
Why?
|
Cough | 1 | 2021 | 598 | 0.030 |
Why?
|
Nitroglycerin | 1 | 2018 | 332 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2022 | 1836 | 0.030 |
Why?
|
Respiratory Sounds | 1 | 2021 | 702 | 0.030 |
Why?
|
Liver Neoplasms | 1 | 2012 | 4363 | 0.030 |
Why?
|
Histocytochemistry | 1 | 2017 | 699 | 0.030 |
Why?
|
Mutation | 1 | 2020 | 30266 | 0.030 |
Why?
|
Aortic Diseases | 1 | 2022 | 741 | 0.030 |
Why?
|
Hypotension | 1 | 2022 | 888 | 0.030 |
Why?
|
Diagnostic Errors | 1 | 2023 | 1281 | 0.030 |
Why?
|
ROC Curve | 1 | 2023 | 3629 | 0.030 |
Why?
|
Aorta, Thoracic | 1 | 2021 | 1112 | 0.030 |
Why?
|
Preventive Health Services | 1 | 2019 | 570 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 2018 | 990 | 0.030 |
Why?
|
Pesticides | 1 | 2016 | 298 | 0.030 |
Why?
|
Dyspnea | 1 | 2021 | 1352 | 0.030 |
Why?
|
SEER Program | 1 | 2018 | 1473 | 0.030 |
Why?
|
Microscopy | 1 | 2017 | 910 | 0.020 |
Why?
|
Water Pollutants, Chemical | 1 | 2016 | 359 | 0.020 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2017 | 1243 | 0.020 |
Why?
|
Age of Onset | 1 | 2019 | 3346 | 0.020 |
Why?
|
Drug-Eluting Stents | 1 | 2018 | 681 | 0.020 |
Why?
|
Brain | 1 | 2017 | 27453 | 0.020 |
Why?
|
Echocardiography | 1 | 2023 | 5047 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2023 | 3941 | 0.020 |
Why?
|
New York City | 1 | 2012 | 737 | 0.020 |
Why?
|
Quality of Health Care | 1 | 2024 | 4339 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2017 | 1751 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3800 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2019 | 1886 | 0.020 |
Why?
|
Hemodynamics | 1 | 2017 | 4199 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2012 | 3438 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15879 | 0.020 |
Why?
|
Recurrence | 1 | 2018 | 8513 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2023 | 20245 | 0.020 |
Why?
|
Peptide Fragments | 1 | 2017 | 5151 | 0.020 |
Why?
|
Neoplasm Invasiveness | 1 | 2012 | 3629 | 0.010 |
Why?
|
Pandemics | 1 | 2023 | 8749 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2022 | 7957 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2012 | 6547 | 0.010 |
Why?
|
Survival Rate | 1 | 2016 | 12873 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2018 | 15471 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2012 | 12095 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2018 | 65480 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12562 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2012 | 9442 | 0.010 |
Why?
|